Tissue remodeling as a feature of persistent asthma.

A chronic inflammatory process is almost invariably associated with tissue damage and healing. Healing results in repair and replacement of dead or damaged cells by viable cells. Repair usually involves 2 distinct processes: regeneration, which is the replacement of injured tissue by parenchymal cells of the same type, and replacement by connective tissue and its eventual maturation into scar tissue. In many instances both processes contribute to the healing response. Chronic inflammatory disease can therefore lead to a wide variety of consequences, from complete or partial restitution of organ structure and function to fibrosis. Asthma is characterized by a chronic inflammatory process of the airways. The ensuing healing process results in structural alterations referred to as a remodeling of the airways. The mechanisms underlying these structural alterations are still largely unknown. They are likely to be heterogeneous, leading-through the highly dynamic process of cell de-differentiation, migration, differentiation, and maturation-to changes in connective tissue deposition and to the altered restitution of airways structure, resulting in mucus gland hyperplasia, neovascularization, fibrosis, and an increase in smooth muscle mass.

[1]  J Bousquet,et al.  Asthma. From bronchoconstriction to airways inflammation and remodeling. , 2000, American journal of respiratory and critical care medicine.

[2]  E. Gelfand,et al.  CD40 and adenosine A2 receptor agonist-cyclic adenosine monophosphate rescue B-cell antigen receptor-induced apoptosis through independent pathways and converge to prevent caspase activation. , 2000, The Journal of allergy and clinical immunology.

[3]  R. Djukanović Asthma: A disease of inflammation and repair. , 2000, The Journal of allergy and clinical immunology.

[4]  E. Minshall,et al.  IL-11 expression is increased in severe asthma: association with epithelial cells and eosinophils. , 2000, The Journal of allergy and clinical immunology.

[5]  R. Pauwels,et al.  Prolonged allergen exposure induces structural airway changes in sensitized rats. , 2000, American journal of respiratory and critical care medicine.

[6]  A. James,et al.  The airway longitudinal elastic fiber network and mucosal folding in patients with asthma. , 2000, American journal of respiratory and critical care medicine.

[7]  V. Casolaro,et al.  Activation of Eotaxin Gene Transcription by NF-κB and STAT6 in Human Airway Epithelial Cells , 1999, The Journal of Immunology.

[8]  M. Humbert,et al.  Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics. , 1999, Journal of immunology.

[9]  R. Pauwels,et al.  The message from the World Asthma Meeting. The Working Groups of the World Asthma Meeting, held in Barcelona, Spain, December 9-13, 1998. , 1999, The European respiratory journal.

[10]  F. Kauffmann,et al.  Gender differences in airway behaviour over the human life span , 1999, Thorax.

[11]  Pauwels,et al.  Airway wall remodelling: does it occur and what does it mean? , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[12]  C. Streuli,et al.  Extracellular matrix remodelling and cellular differentiation. , 1999, Current opinion in cell biology.

[13]  Bousquet,et al.  VEGF levels in asthmatic airways do not correlate with plasma extravasation , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[14]  G Murphy,et al.  Proteolysis and cell migration: creating a path? , 1999, Current opinion in cell biology.

[15]  S. Wenzel,et al.  Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. , 1999, American journal of respiratory and critical care medicine.

[16]  J. Bousquet,et al.  Balance in asthma between matrix metalloproteinases and their inhibitors. , 1999, The Journal of allergy and clinical immunology.

[17]  P. Saldiva,et al.  Elastosis and fragmentation of fibers of the elastic system in fatal asthma. , 1999, American journal of respiratory and critical care medicine.

[18]  S. Peters,et al.  Airway remodeling and persistent airway obstruction in asthma. , 1999, The Journal of allergy and clinical immunology.

[19]  K. Chung,et al.  Cytokines in asthma , 1999, Thorax.

[20]  K. Chung,et al.  Repeated allergen exposure of sensitized Brown-Norway rats induces airway cell DNA synthesis and remodelling. , 1999, The European respiratory journal.

[21]  M. Kurimoto,et al.  Airway epithelium expresses interleukin-18. , 1999, The European respiratory journal.

[22]  A. Nagler,et al.  Human Eosinophils Regulate Human Lung- and Skin-Derived Fibroblast Properties in vitro: A Role for Transforming Growth Factor β (TGF-β) , 1999 .

[23]  M. Hoshino,et al.  Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. , 1999, The Journal of allergy and clinical immunology.

[24]  R. Pellegrino,et al.  Airway responsiveness to methacholine: effects of deep inhalations and airway inflammation. , 1999, Journal of applied physiology.

[25]  P. Holt,et al.  Functional studies on dendritic cells in the respiratory tract and related mucosal tissues , 1999, Journal of leukocyte biology.

[26]  C. Legrand,et al.  Airway Epithelial Cell Migration Dynamics , 1999, The Journal of cell biology.

[27]  L. Boulet,et al.  Asymptomatic airway hyperresponsiveness: relationships with airway inflammation and remodelling. , 1999, The European respiratory journal.

[28]  V. Everts,et al.  Inhibition of contact sensitizer-induced migration of human Langerhans cells by matrix metalloproteinase inhibitors , 1999, Archives of Dermatological Research.

[29]  P. Kalinski,et al.  The paradigm of type 1 and type 2 antigen‐presenting cells. Implications for atopic allergy , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[30]  S. Shapiro,et al.  Matrix metalloproteinases. Matrix degradation and more. , 1999, American journal of respiratory cell and molecular biology.

[31]  S. Holgate,et al.  The bronchial epithelium as a key regulator of airway inflammation and remodelling in asthma , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[32]  K. Lutchen,et al.  Airway remodeling in asthma amplifies heterogeneities in smooth muscle shortening causing hyperresponsiveness. , 1999, Journal of applied physiology.

[33]  A. Harf,et al.  Overexpression of alveolar macrophage gelatinase B (MMP-9) in patients with idiopathic pulmonary fibrosis: effects of steroid and immunosuppressive treatment. , 1999, American journal of respiratory cell and molecular biology.

[34]  W. Stetler-Stevenson,et al.  Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. , 1999, The Journal of clinical investigation.

[35]  C. Reed The natural history of asthma in adults: the problem of irreversibility. , 1999, The Journal of allergy and clinical immunology.

[36]  S. Holgate,et al.  Growth factors secreted by bronchial epithelial cells control myofibroblast proliferation: an in vitro co-culture model of airway remodeling in asthma. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[37]  V. Fadok,et al.  "Their's but to do and die": eosinophil longevity in asthma. , 1999, The Journal of allergy and clinical immunology.

[38]  J. Bousquet,et al.  Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis. , 1999, The Journal of allergy and clinical immunology.

[39]  J. Vandenbroucke,et al.  Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. , 1999, American journal of respiratory and critical care medicine.

[40]  F. Thien,et al.  Vascularity in asthmatic airways: relation to inhaled steroid dose. , 1999, Thorax.

[41]  W. Busse,et al.  Segmental antigen challenge increases fibronectin in bronchoalveolar lavage fluid. , 1999, American journal of respiratory and critical care medicine.

[42]  P. Cohen,et al.  Elevated levels of the IGF-binding protein protease MMP-1 in asthmatic airway smooth muscle. , 1999, American journal of respiratory cell and molecular biology.

[43]  R. Low Modulation of myofibroblast and smooth-muscle phenotypes in the lung. , 1999, Current topics in pathology. Ergebnisse der Pathologie.

[44]  R. Meiss Influence of intercellular tissue connections on airway muscle mechanics. , 1999, Journal of applied physiology.

[45]  M. Arima,et al.  Expression of interleukin-16 by human epithelial cells. Inhibition by dexamethasone. , 1999, American journal of respiratory cell and molecular biology.

[46]  S. Wenzel,et al.  Collagen deposition in large airways may not differentiate severe asthma from milder forms of the disease. , 1998, American journal of respiratory and critical care medicine.

[47]  P. Howarth,et al.  Co‐localization of immunoreactive transforming growth factor‐beta1 and decorin in bronchial biopsies from asthmatic and normal subjects , 1998, The Journal of pathology.

[48]  J. Bousquet,et al.  Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. , 1998, American journal of respiratory and critical care medicine.

[49]  S. Isogai,et al.  Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. , 1998, The Journal of allergy and clinical immunology.

[50]  R. Panettieri Cellular and molecular mechanisms regulating airway smooth muscle proliferation and cell adhesion molecule expression. , 1998, American journal of respiratory and critical care medicine.

[51]  J Vestbo,et al.  A 15-year follow-up study of ventilatory function in adults with asthma. , 1998, The New England journal of medicine.

[52]  L. Boulet,et al.  Clinical, physiological and radiological features of asthma with incomplete reversibility of airflow obstruction compared with those of COPD. , 1998, Canadian respiratory journal.

[53]  Y. Nasuhara,et al.  Expression of epidermal growth factor and epidermal growth factor receptor immunoreactivity in the asthmatic human airway. , 1998, American journal of respiratory and critical care medicine.

[54]  J. Lasky,et al.  Dexamethasone activates expression of the PDGF-α receptor and induces lung fibroblast proliferation. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[55]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[56]  R. Lipscombe,et al.  Interleukin‐5 binds to heparin/heparan sulfate. A model for an interaction with extracellular matrix , 1998, Journal of leukocyte biology.

[57]  P. Jeffery,et al.  Structural and inflammatory changes in COPD: a comparison with asthma. , 1998, Thorax.

[58]  M. Stacey,et al.  Endothelin-1 Induces Bronchial Myofibroblast Differentiation , 1997, Peptides.

[59]  F. Levi-Schaffer,et al.  Anti‐apoptotic signals of granulocyte‐macrophage colony‐stimulating factor are transduced via Jak2 tyrosine kinase in eosinophils , 1997, European journal of immunology.

[60]  R D Kamm,et al.  On the mechanism of mucosal folding in normal and asthmatic airways. , 1997, Journal of applied physiology.

[61]  J. Bousquet,et al.  Significance of emphysema observed on computed tomography scan in asthma. , 1997, The European respiratory journal.

[62]  J. Bousquet,et al.  Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. , 1997, American journal of respiratory cell and molecular biology.

[63]  R. Patterson,et al.  Airways obstruction in patients with long-term asthma consistent with 'irreversible asthma'. , 1997, Chest.

[64]  S. Wenzel,et al.  Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. , 1997, American journal of respiratory and critical care medicine.

[65]  R. Martin,et al.  Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. , 1997, American journal of respiratory cell and molecular biology.

[66]  I. Virtanen,et al.  Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. , 1997, American journal of respiratory and critical care medicine.

[67]  J. Bousquet,et al.  Transforming Growth Factor- β Expression in Mucosal Biopsies in Asthma and Chronic Bronchitis , 1997 .

[68]  J. Fredberg,et al.  Perhaps airway smooth muscle dysfunction contributes to asthmatic bronchial hyperresponsiveness after all. , 1997, American journal of respiratory cell and molecular biology.

[69]  P. Howarth,et al.  Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. , 1997, American journal of respiratory and critical care medicine.

[70]  J. Wilson,et al.  Increased vascularity of the bronchial mucosa in mild asthma. , 1997, American journal of respiratory and critical care medicine.

[71]  A. Casalini,et al.  Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. , 1997, American journal of respiratory and critical care medicine.

[72]  P. O'Byrne,et al.  Myofibroblast involvement in the allergen-induced late response in mild atopic asthma. , 1997, American journal of respiratory cell and molecular biology.

[73]  C. W. Kim,et al.  High-resolution computed tomography in patients with bronchial asthma: correlation with clinical features, pulmonary functions and bronchial hyperresponsiveness. , 1997, Journal of investigational allergology & clinical immunology.

[74]  N L Müller,et al.  Airway obstruction in asthmatic and healthy individuals: inspiratory and expiratory thin-section CT findings. , 1997, Radiology.

[75]  D. Postma,et al.  Adult patients may outgrow their asthma: a 25-year follow-up study. , 1997, American journal of respiratory and critical care medicine.

[76]  Airway remodelling takes place in asthma — what are the clinical implications? , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[77]  D Olivieri,et al.  Airways remodeling is a distinctive feature of asthma and is related to severity of disease. , 1997, Chest.

[78]  J. Cairns,et al.  Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. , 1997, The Journal of clinical investigation.

[79]  K. Shirato,et al.  Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. , 1997, American journal of respiratory cell and molecular biology.

[80]  K. Chung,et al.  Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids. , 1997, Journal of immunology.

[81]  Kay Ab T cells as orchestrators of the asthmatic response. , 1997 .

[82]  M Nathan,et al.  Friction in airway smooth muscle: mechanism, latch, and implications in asthma. , 1996, Journal of applied physiology.

[83]  L. Boulet,et al.  Lower airways remodeling in nonasthmatic subjects with allergic rhinitis. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[84]  H. Hoogsteden,et al.  Effects of fluticasone propionate on methacholine dose-response curves in nonsmoking atopic asthmatics. , 1996, The European respiratory journal.

[85]  J. Bousquet,et al.  Release of transforming growth factor‐beta (TGF‐β) and fibronectin by alveolar macrophages in airway diseases , 1996, Clinical and experimental immunology.

[86]  P. Venge,et al.  Expression of laminins in the airways in various types of asthmatic patients: a morphometric study. , 1996, American journal of respiratory cell and molecular biology.

[87]  D. Postma,et al.  Is delayed introduction of inhaled corticosteroids harmful in patients with obstructive airways disease (asthma and COPD)? The Dutch CNSLD Study Group. The Dutch Chronic Nonspecific Lung Disease Study Groups. , 1996, Chest.

[88]  Airway behavior and its regulation: how do structural changes affect airway behavior? , 1996, American journal of respiratory and critical care medicine.

[89]  A. Halayko,et al.  Markers of airway smooth muscle cell phenotype. , 1996, The American journal of physiology.

[90]  J. Bousquet,et al.  Bronchial elastic fibers in normal subjects and asthmatic patients. , 1996, American journal of respiratory and critical care medicine.

[91]  T. Ley,et al.  Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[92]  Hirst Sj Airway smooth muscle cell culture: application to studies of airway wall remodelling and phenotype plasticity in asthma. , 1996 .

[93]  L. Picker,et al.  CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway , 1996, The Journal of experimental medicine.

[94]  J. Warner,et al.  Effects of integrin clustering on human lung mast cells and basophils. , 1996, American journal of respiratory cell and molecular biology.

[95]  P. Macklem,et al.  A theoretical analysis of the effect of airway smooth muscle load on airway narrowing. , 1996, American journal of respiratory and critical care medicine.

[96]  J. Bousquet,et al.  Computed tomography of the lungs in asthma: influence of disease severity and etiology. , 1996, American journal of respiratory and critical care medicine.

[97]  J. Roman Extracellular matrix and lung inflammation , 1996, Immunologic research.

[98]  M. Infeld,et al.  Effect of elastase on the directional migration of lung fibroblasts within a three-dimensional collagen matrix. , 1995, Experimental lung research.

[99]  R. Schellenberg,et al.  Collagenase increases shortening of human bronchial smooth muscle in vitro. , 1995, American journal of respiratory and critical care medicine.

[100]  A Pietinalho,et al.  Effect of early vs late intervention with inhaled corticosteroids in asthma. , 1995, Chest.

[101]  J. Bousquet,et al.  Platelet‐derived growth factor in asthma , 1995, Allergy.

[102]  E. Zerhouni,et al.  Airway edema potentiates airway reactivity. , 1995, Journal of applied physiology.

[103]  A. Stewart,et al.  Salbutamol inhibits the proliferation of human airway smooth muscle cells grown in culture: relationship to elevated cAMP levels. , 1995, Biochemical pharmacology.

[104]  K. Ohno,et al.  Transforming growth factor beta 1 preferentially induces apoptotic cell death in rat hepatocytes cultured under pericentral-equivalent conditions. , 1995, Toxicology and applied pharmacology.

[105]  Heterogeneity of airways obstruction in asthmatic patients using high-resolution computed tomography. , 1995, Chest.

[106]  P. Black,et al.  Effects of glucocorticoids and beta-adrenoceptor agonists on the proliferation of airway smooth muscle. , 1995, European journal of pharmacology.

[107]  P. Lange,et al.  Decline of lung function in adults with bronchial asthma. , 1994, American journal of respiratory and critical care medicine.

[108]  S. Codd,et al.  Physical determinants of bronchial mucosal folding. , 1994, Journal of applied physiology.

[109]  C. Haslett,et al.  Granulocyte apoptosis and the control of inflammation. , 1994, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[110]  K. Hamann,et al.  Augmentation of stimulated eosinophil degranulation by VLA-4 (CD49d)-mediated adhesion to fibronectin. , 1994, American journal of respiratory cell and molecular biology.

[111]  H. Magnussen,et al.  Passive sensitization of human bronchi augments smooth muscle shortening velocity and capacity. , 1994, The American journal of physiology.

[112]  M. Calderón,et al.  Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. , 1994, American journal of respiratory and critical care medicine.

[113]  C. Ulrik,et al.  Different bronchodilating effect of salmeterol and formoterol in an adult asthmatic. , 1994, The European respiratory journal.

[114]  S. Pedersen,et al.  Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. , 1994, Respiratory medicine.

[115]  M. Hughes,et al.  Remission of childhood asthma after long-term treatment with an inhaled corticosteroid (budesonide): can it be achieved? Dutch CNSLD Study Group. , 1994, The European respiratory journal.

[116]  P. Paré,et al.  Small airways dimensions in asthma and in chronic obstructive pulmonary disease. , 1993, The American review of respiratory disease.

[117]  T. Walz,et al.  Production of transforming growth factor alpha by normal human blood eosinophils. , 1993, Leukemia.

[118]  M. Ebina,et al.  Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. , 1993, The American review of respiratory disease.

[119]  J. Bousquet,et al.  HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis. , 1993, The American review of respiratory disease.

[120]  A. Sousa,et al.  Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids. , 1993, The American review of respiratory disease.

[121]  J. Bousquet,et al.  Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung. , 1993, The American review of respiratory disease.

[122]  J. Hogg,et al.  Functional significance of increased airway smooth muscle in asthma and COPD. , 1993, Journal of applied physiology.

[123]  C. van Weel,et al.  Slowing the Deterioration of Asthma and Chronic Obstructive Pulmonary Disease Observed during Bronchodilator Therapy by Adding Inhaled Corticosteroids: A 4-Year Prospective Study , 1993, Annals of Internal Medicine.

[124]  A. Wardlaw,et al.  Adhesion to fibronectin prolongs eosinophil survival , 1993, Journal of Experimental Medicine.

[125]  A. James,et al.  The structure of large and small airways in nonfatal and fatal asthma. , 1993, The American review of respiratory disease.

[126]  M. Jordana Mast cells and fibrosis--who's on first? , 1993, American Journal of Respiratory Cell and Molecular Biology.

[127]  W. Schlick Current issues in the assessment of interstitial lung disease. , 1993, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[128]  M. Sheppard,et al.  New perspectives on basic mechanisms in lung disease. 1. Lung injury, inflammatory mediators, and fibroblast activation in fibrosing alveolitis. , 1992, Thorax.

[129]  K. Fukuda,et al.  Secretion of hyaluronic acid from synovial fibroblasts is enhanced by histamine: a newly observed metabolic effect of histamine. , 1992, The Journal of laboratory and clinical medicine.

[130]  A. Kay,et al.  Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumour necrosis factor-alpha. , 1992, Immunology.

[131]  A. Zwinderman,et al.  Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. , 1992, The New England journal of medicine.

[132]  J. Bousquet,et al.  Chest radiography and high resolution computed tomography of the lungs in asthma. , 1992, The American review of respiratory disease.

[133]  M. Hughes,et al.  Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. , 1992, The American review of respiratory disease.

[134]  S. McGowan Extracellular matrix and the regulation of lung development and repair 1 , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[135]  C. Harley,et al.  Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). , 1992, The Journal of clinical investigation.

[136]  R. Crystal,et al.  Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. , 1992, The Journal of clinical investigation.

[137]  P. Jeffery,et al.  Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. , 1992, The American review of respiratory disease.

[138]  J. Bousquet,et al.  Asthma: a disease remodeling the airways , 1992, Allergy.

[139]  A. Dirksen,et al.  A 10 year follow up of 180 adults with bronchial asthma: factors important for the decline in lung function. , 1992, Thorax.

[140]  Z. Werb,et al.  Chapter 54 The role of macrophage-derived growth factors in tissue repair , 1992 .

[141]  F. Speizer,et al.  Effects of asthma on pulmonary function in children. A longitudinal population-based study. , 1992, The American review of respiratory disease.

[142]  J. Oppenheim,et al.  Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. , 1992, Immunology today.

[143]  L. Fabbri,et al.  Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate. , 1992, The American review of respiratory disease.

[144]  T. Colby,et al.  Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. , 1992, The American journal of pathology.

[145]  L. Fabbri,et al.  Effect of cessation of exposure to toluene diisocyanate (TDI) on bronchial mucosa of subjects with TDI-induced asthma. , 1992, The American review of respiratory disease.

[146]  J. Bousquet,et al.  Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. , 1991, The Journal of allergy and clinical immunology.

[147]  J. Zahm,et al.  Wound repair of human surface respiratory epithelium. , 1991, American journal of respiratory cell and molecular biology.

[148]  T. Haahtela,et al.  Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. , 1991, The New England journal of medicine.

[149]  T. Hartmann,et al.  Mast cell tryptase is a mitogen for cultured fibroblasts. , 1991, The Journal of clinical investigation.

[150]  P. Sterk,et al.  The shape of the dose-response curve to inhaled bronchoconstrictor agents in asthma and in chronic obstructive pulmonary disease. , 1991, The American review of respiratory disease.

[151]  D. Metcalfe,et al.  Murine mast cells synthesize basement membrane components. A potential role in early fibrosis. , 1991, The Journal of clinical investigation.

[152]  A. Zwinderman,et al.  The effect of inhaled corticosteroids on the maximal degree of airway narrowing to methacholine in asthmatic subjects. , 1991, The American review of respiratory disease.

[153]  R. Stockley,et al.  Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium. , 1991, American journal of respiratory cell and molecular biology.

[154]  P. Howarth,et al.  Myofibroblasts and subepithelial fibrosis in bronchial asthma. , 1990, American journal of respiratory cell and molecular biology.

[155]  H. Yaegashi,et al.  Distribution of smooth muscles along the bronchial tree. A morphometric study of ordinary autopsy lungs. , 1990, The American review of respiratory disease.

[156]  E. Bleecker,et al.  Peripheral lung resistance in normal and asthmatic subjects. , 1990, The American review of respiratory disease.

[157]  T. Bai,et al.  Abnormalities in airway smooth muscle in fatal asthma. , 1990, The American review of respiratory disease.

[158]  S. Wahl,et al.  Inflammation and Repair , 1990 .

[159]  P. Anthony Robbins' Pathologic Basis of Disease , 1990 .

[160]  A. Wardlaw,et al.  Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. , 1989, The American review of respiratory disease.

[161]  S. Holgate,et al.  SUBEPITHELIAL FIBROSIS IN THE BRONCHI OF ASTHMATICS , 1989, The Lancet.

[162]  P. Paré,et al.  The mechanics of airway narrowing in asthma. , 1989, The American review of respiratory disease.

[163]  A. Woolcock,et al.  Rate of decline of lung function in subjects with asthma. , 1987, European journal of respiratory diseases.

[164]  P. Paré,et al.  Mechanics of airway narrowing. , 2015 .

[165]  G. Snider,et al.  Distinguishing among asthma, chronic bronchitis, and emphysema. , 1985, Chest.

[166]  C. Salome,et al.  The shape of the dose-response curve to histamine in asthmatic and normal subjects. , 2015, The American review of respiratory disease.

[167]  A. Cats,et al.  HL-A 27 AND ANKYLOSING SPONDYLITIS , 1975, The Lancet.

[168]  B. Heard,et al.  Hyperplasia of bronchial muscle in chronic bronchitis , 1970, The Journal of pathology.

[169]  J. Anderson,et al.  A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema , 1969, Thorax.

[170]  M. Dunnill THE PATHOLOGY OF ASTHMA, WITH SPECIAL REFERENCE TO CHANGES IN THE BRONCHIAL MUCOSA , 1960, Journal of clinical pathology.